- Advanced Assisted Reproduction
IVF and ICSI Treatment:Complete Guide to Procedure, Success Rates and Costs
IVF (In Vitro Fertilisation) and ICSI (Intracytoplasmic Sperm Injection) are the most effective fertility treatments available, helping couples overcome blocked tubes, severe male factor infertility, diminished ovarian reserve, endometriosis, and unexplained infertility. At Samarth IVF, we deliver internationally benchmarked success rates across 14 centres in India, combining advanced laboratory technology, personalised stimulation protocols, and specialist embryology to give every patient the best possible chance of having a baby.
What is IVF (In Vitro Fertilisation)?
IVF stands for In Vitro Fertilisation. In Vitro means outside the body. In an IVF cycle, the ovaries are stimulated with hormone injections to develop multiple eggs. These eggs are retrieved under sedation and fertilised with sperm in the embryology laboratory. The resulting embryos are cultured for 3 to 6 days and the best quality embryo is selected and transferred into the uterus. Any additional good-quality embryos are frozen for future use.
IVF was first developed in 1978 with the birth of Louise Brown, the world’s first IVF baby. Since then, over 12 million babies have been born worldwide through IVF. Today, IVF is a routine, well-established medical procedure offered at thousands of centres globally, with success rates continuing to improve year on year through advances in laboratory culture conditions, embryo selection technology, and personalised stimulation protocols.
IVF is indicated when simpler treatments such as IUI have failed or when the diagnosis makes simpler treatments unlikely to succeed. It offers the highest per-cycle pregnancy rates of any fertility treatment, making it the most efficient path to parenthood for many couples.
What is ICSI?
ICSI (Intracytoplasmic Sperm Injection) is a specialised form of IVF in which a single sperm is selected by the embryologist and injected directly into each mature egg using a microscopic glass needle.
In standard IVF, sperm are placed around the egg in a dish and fertilisation occurs naturally when a sperm penetrates the egg independently. ICSI removes the need for the sperm to penetrate the egg on its own, making it the treatment of choice for all forms of male factor infertility and for situations where standard IVF fertilisation rates are expected to be low.
ICSI achieves fertilisation rates of 70 to 85 percent per injected egg, regardless of sperm quality, as long as the sperm is viable and the egg is mature. Today, ICSI is used in the majority of IVF cycles worldwide, not only for male factor indications but also as a precautionary measure to maximise fertilisation rates in any cycle where egg numbers are limited.
IVF vs. ICSI: When Each is Used
| FACTOR | NATURAL HATCHING | LASER ASSISTED HATCHING |
|---|---|---|
| How zona is breached | Enzymatic and pressure-driven by embryo | Precise infrared laser pulse creates opening |
| Timing of hatching | Variable, depends on embryo | Facilitated by pre-made opening before transfer |
| Suitable for all embryos | Yes, standard process | Selective: indicated cases only |
| Benefit for frozen embryos | Zona may be harder after freeze-thaw | LAH overcomes post-thaw zona changes |
| Risk | Hatching failure if zona is too thick | Minimal: rare monozygotic twin risk |
Who Needs IVF or ICSI?
IVF and ICSI are recommended for a wide range of fertility diagnoses. At Samarth IVF, treatment recommendations are always based on thorough investigation and a genuine assessment of which treatment gives each couple the best probability of success.
IVF Indications
Bilateral fallopian tube blockage
Both tubes are blocked, making natural conception or IUI impossible. IVF bypasses the tubes entirely. This is one of the most clear-cut indications for IVF.
Endometriosis
Moderate to severe endometriosis reduces natural fertility and IUI success significantly. IVF with stimulation and embryo transfer bypasses the affected pelvic environment.
Ovulation disorders
Women with PCOS or other ovulatory disorders who have not conceived after ovulation induction and IUI cycles.
Diminished ovarian reserve
Women with low AMH or AFC benefit from IVF, which maximises the number of eggs retrieved per cycle. Tailored stimulation protocols optimise egg yield even in low-reserve patients.
Failed IUI cycles
Couples who have completed 3 to 6 well-monitored IUI cycles without success should progress to IVF.
Unexplained infertility of longer duration
When all standard investigations are normal but pregnancy has not occurred after 2 or more years, IVF offers the highest per-cycle success rate.
Advanced maternal age
Women above 37 to 38 have declining egg quality and quantity. IVF allows retrieval of multiple eggs, increasing the chance of obtaining good quality embryos. PGT-A can screen embryos for chromosomal normality.
Genetic conditions requiring PGT
When either partner carries a genetic condition, Preimplantation Genetic Testing (PGT-M for monogenic conditions or PGT-SR for chromosomal rearrangements) allows only unaffected embryos to be transferred.
Recurrent miscarriage
PGT-A screens embryos for chromosomal abnormality before transfer, significantly reducing miscarriage rates in couples with recurrent pregnancy loss due to embryo aneuploidy.
ICSI Indications:
Severe oligospermia
sperm count below 5 million per mL
Severe asthenospermia
very poor sperm motility
Severe teratospermia
very high proportion of abnormal morphology
Azoospermia with surgically retrieved sperm
(TESA, PESA, micro-TESE)
Previous IVF cycle with poor or failed fertilisation
High sperm DNA fragmentation
Eggs retrieved from frozen storage
(vitrified eggs)
Low egg number
where maximising fertilisation rate is critical
The IVF and ICSI Process at Samarth IVF: Step by Step
A complete IVF or ICSI cycle typically spans 4 to 6 weeks from the start of stimulation to the pregnancy test. Below is a detailed walkthrough of every stage in the process at Samarth IVF.
Stage 1: Pre-IVF Investigation and Consultation
Before beginning an IVF cycle, your Samarth IVF specialist reviews all investigation results for both partners. If investigations are incomplete, the missing tests are ordered. Your consultant discusses your diagnosis, the proposed stimulation protocol, the expected number of eggs based on AFC and AMH, the role of ICSI, embryo transfer strategy, and realistic success probabilities. Any questions about the process, risks, medications, and costs are addressed at this consultation. Both partners must attend and consent to treatment.
Stage 2: Down-Regulation or Cycle Preparation
The IVF stimulation protocol is chosen based on your ovarian reserve, age, previous response, and diagnosis. The two main protocol types are:
GnRH Antagonist Protocol (Short Protocol): Currently the most widely used protocol worldwide and at Samarth IVF. Stimulation injections begin on Day 2 or 3 of the menstrual cycle. A GnRH antagonist injection is added from Day 5 to 6 to prevent premature LH surge and ovulation before egg retrieval. This protocol is shorter (10 to 12 days of injections), is associated with lower OHSS risk, and is the preferred protocol for PCOS and normal responders.
GnRH Agonist Long Protocol: Involves a course of GnRH agonist (typically nasal spray or injections) starting in the luteal phase of the preceding cycle to suppress the pituitary before stimulation begins. This produces a more controlled and synchronised response. Still used in selected cases, particularly for previous poor responders or certain endometriosis cases.
Mini-IVF (Minimal Stimulation IVF): Uses lower doses of stimulation to retrieve fewer but potentially higher-quality eggs. Suited for poor responders, women with very low reserve, or as a cost-reduction strategy. At Samarth IVF, mini-IVF protocols are offered to appropriate candidates.
Stage 3: Ovarian Stimulation with Gonadotrophin Injections
Daily subcutaneous (under-skin) injections of FSH, or a combination of FSH and LH, are administered from Day 2 to 3 of the cycle. These injections stimulate the ovaries to develop multiple follicles simultaneously rather than the single follicle that develops in a natural cycle. The injections are self-administered at home after a brief training session. Most patients find them straightforward to manage.
The goal is to develop an adequate cohort of follicles (typically 8 to 15 in normal responders) without over-stimulating. The dose is tailored to each patient's AMH, AFC, weight, and protocol type. Starting doses range from 150 IU to 300 IU per day and may be adjusted during stimulation based on monitoring results.
Stage 4: Follicle Monitoring During Stimulation
Serial transvaginal ultrasound scans are performed every 1 to 2 days during stimulation, typically starting on Day 5 to 6 of injections. Each scan measures the number and size of developing follicles in both ovaries and assesses endometrial thickness. Estradiol blood tests may be performed alongside scans to assess the hormonal response. The stimulation dose is adjusted based on scan findings. Monitoring continues until the lead follicles reach 17 to 18 mm in diameter, indicating egg maturity.
Stage 5: Trigger Injection
When 2 or more follicles have reached 17 to 18 mm in diameter, a trigger injection is administered. This triggers the final maturation of eggs inside the follicles. Two trigger options are used:
hCG trigger (Ovitrelle, Pregnyl): The traditional trigger. Egg retrieval is scheduled exactly 36 hours after the trigger injection.
GnRH agonist trigger: Used instead of hCG in women at high OHSS risk (particularly PCOS patients with large numbers of follicles). Reduces OHSS risk significantly. When an agonist trigger is used, a freeze-all strategy is typically employed, with all embryos frozen and transferred in a later frozen embryo transfer cycle.
Stage 6: Egg Retrieval (Ovum Pick-Up / OPU)
Egg retrieval is performed exactly 36 hours after the trigger injection as a day-procedure under intravenous sedation. No general anaesthesia is required. A transvaginal ultrasound probe with a fine needle guide is used to aspirate fluid from each follicle through the vaginal wall. Each follicle is aspirated individually and the fluid is immediately passed to the embryologist in the adjacent laboratory, who identifies the egg under the microscope.
The procedure takes approximately 15 to 30 minutes. Most women experience mild cramping during and after the procedure, managed with oral pain relief. Discharge is typically 2 to 4 hours after the procedure. Light spotting and mild pelvic discomfort for 1 to 2 days after egg retrieval is normal. The number of eggs retrieved depends on the number of mature follicles developed during stimulation.
Stage 7: Sperm Collection and Preparation on the Day of Egg Retrieval
On the same morning as egg retrieval, the male partner provides a semen sample. The sample is processed in the andrology laboratory. For standard IVF, the prepared sperm is added to each egg in the culture dish. For ICSI, the embryologist selects individual sperm under high magnification and injects one directly into each mature egg using a glass micropipette.
Stage 8: Fertilisation and Embryo Culture
Fertilisation is checked 16 to 18 hours after insemination or ICSI. Normal fertilisation is confirmed by the appearance of two pronuclei (2PN) inside the egg, indicating that one nucleus from the sperm and one from the egg are present and the egg has fertilised correctly. Fertilisation rates with ICSI are typically 70 to 85 percent of mature eggs.
Fertilised eggs (now called embryos or zygotes) are cultured in the embryology laboratory in specialised incubators that precisely replicate the conditions of the fallopian tube and uterus, including temperature, humidity, oxygen concentration, and pH. Embryos are assessed daily for their developmental progress. They are classified and graded by the embryologist based on established morphological criteria.
Stage 9: Embryo Development and Grading
Embryo development follows a predictable timeline. On Day 2 the embryo should have 2 to 4 cells. On Day 3 it should have 6 to 8 cells. By Day 5 to 6 a well-developing embryo reaches the blastocyst stage, which consists of over 100 cells organised into two distinct cell populations. Blastocyst transfer is preferred at Samarth IVF as it identifies embryos with the highest implantation potential and reduces multiple pregnancy rates.
Embryos are graded on multiple parameters. At the cleavage stage, grading assesses cell number, symmetry, and the degree of fragmentation. At the blastocyst stage, grading separately assesses the development of the blastocoel cavity, the inner cell mass, and the trophectoderm. Only embryos meeting quality thresholds are selected for transfer or freezing.
Stage 10: Embryo Transfer
Embryo transfer is a simple, painless outpatient procedure that does not require anaesthesia. A thin, soft catheter is passed through the cervix into the uterine cavity under ultrasound guidance. The selected embryo, suspended in a tiny droplet of culture medium, is gently released into the uterine cavity at the optimal position. The transfer typically takes 5 to 10 minutes.
At Samarth IVF, single embryo transfer (SET) is the standard recommendation for most patients under 38 with good quality embryos. SET eliminates the risk of multiple pregnancy while maintaining excellent pregnancy rates when embryo quality and endometrial receptivity are optimised. Double embryo transfer is considered in selected cases where SET is unlikely to be sufficient, based on age, embryo quality, and clinical history.
Fresh transfer (in the same cycle as egg retrieval) or frozen embryo transfer (FET, in a subsequent cycle after freezing all embryos) is recommended based on clinical circumstances. Freeze-all strategies are used when OHSS risk is elevated, when the endometrial lining is suboptimal, when an agonist trigger was used, or when PGT results are awaited.
Stage 11: Luteal Phase Support
After embryo transfer, progesterone supplementation is prescribed to support the uterine lining and early implantation. This is given as vaginal pessaries (Crinone gel, Utrogestan), injections (Gestone), or oral micronised progesterone, depending on individual protocol and response. Progesterone support continues until the pregnancy test and, if positive, until 10 to 12 weeks of pregnancy when the placenta takes over progesterone production.
Stage 12: Pregnancy Test
A blood beta-hCG pregnancy test is performed 14 days after embryo transfer. A positive hCG result confirms implantation has occurred. A confirmatory scan is performed 2 weeks later to confirm a clinical pregnancy with a fetal heartbeat. A negative test does not mean future IVF attempts will also fail. Your specialist will review the cycle in detail and discuss whether adjustments to the protocol, stimulation, or transfer strategy can improve outcomes in a subsequent attempt.
IVF and ICSI Success Rates at Samarth IVF
IVF success rates are most accurately expressed as the percentage of embryo transfers resulting in a live birth. The following gives a realistic picture of expected outcomes at Samarth IVF based on internationally benchmarked performance data.
| Female Age Group | Success Rate Per Transfer (Own Eggs) | Notes |
|---|---|---|
| Under 35 | 45 to 55 percent | Best outcomes with fresh or frozen own eggs |
| 35 to 37 | 35 to 45 percent | Decline begins, PGT-A improves outcomes |
| 38 to 40 | 25 to 35 percent | Egg quality declining, more cycles may be needed |
| 41 to 42 | 15 to 25 percent | Egg donation often more efficient |
| With donor eggs (any age) | 50 to 60 percent | Reflects donor age, not recipient age |
Cumulative Success Rates Across Multiple Cycles
For patients under 38, cumulative live birth rates across 3 complete IVF cycles (including frozen embryo transfers from each stimulation cycle) reach 65 to 80 percent. This is why it is important not to judge IVF success on a single cycle but to plan treatment across a realistic number of attempts. At Samarth IVF, your specialist will discuss a realistic multi-cycle plan based on your age, reserve, and response from any previous cycles.
Factors That Influence IVF Success
Female age:
The single most important factor. Younger women have better egg quality and higher implantation rates.
Ovarian reserve:
Higher AMH and AFC generally correlate with better egg yield and more embryos available for selection.
Embryo quality:
Blastocyst-stage embryos with high morphological grades have the highest implantation rates.
Endometrial receptivity:
A well-prepared, triple-line endometrium of adequate thickness supports implantation.
Uterine cavity normality:
Absence of polyps, fibroids, adhesions, or other cavity abnormalities.
Sperm quality:
High DNA fragmentation, even with normal standard parameters, can impair embryo development.
Number of previous failed cycles:
While each cycle is independent, cumulative data from the same patient informs protocol adjustments.
Lifestyle factors:
Smoking, BMI outside the normal range, and alcohol significantly reduce IVF success rates.
Laboratory quality:
The embryology laboratory, culture conditions, and embryologist experience are critical determinants of embryo development quality.
Frozen Embryo Transfer (FET)at Samarth IVF
When multiple good-quality embryos are created in an IVF cycle, surplus embryos are vitrified (flash-frozen) and stored. Frozen embryo transfer (FET) allows these embryos to be used in subsequent cycles without repeating the ovarian stimulation and egg retrieval process, at lower cost and with less physical demand.
Vitrification is the gold-standard embryo freezing technique. It uses ultra-rapid cooling rates to prevent the formation of ice crystals that would damage the embryo. Survival rates of vitrified embryos after thawing are above 95 percent at Samarth IVF. Importantly, multiple studies and clinical data confirm that frozen-thawed embryo transfers achieve comparable or in some cases better pregnancy rates than fresh transfers, as the uterine environment is often better prepared in a dedicated FET cycle.
FET Protocols
Natural cycle FET:
The frozen embryo is thawed and transferred in a natural menstrual cycle around the time of natural ovulation. Best for women with regular, predictable ovulation.
Hormonal replacement cycle FET (HRC-FET):
Oestrogen is given to build the endometrial lining and progesterone is started to replicate the luteal phase. Transfer timing is precisely controlled. This is the most widely used FET protocol as it does not rely on natural ovulation.
Mildly stimulated FET:
Low-dose stimulation with a trigger injection for ovulation followed by progesterone support and transfer. Less commonly used but appropriate in selected cases.
Advanced IVF Technologies at Samarth IVF
Blastocyst Culture
Culturing embryos to Day 5 to 6 blastocyst stage before transfer selects the most developmentally competent embryos, as only approximately 50 percent of fertilised eggs reach the blastocyst stage. Blastocyst transfer consistently achieves higher implantation rates per transfer and is the standard approach at Samarth IVF for patients with adequate embryo numbers. For more detail, see our dedicated Blastocyst Culture page.
Laser Assisted Hatching (LAH)
Before implantation, the embryo must break out of its outer shell (zona pellucida), a process called hatching. LAH uses a precise laser pulse to create a small opening in the zona pellucida, facilitating hatching in embryos where this process may be impaired. LAH is recommended for frozen-thawed embryos, embryos with thick zona pellucida, and in patients with repeated implantation failure.
IMSI
IMSI uses ultra-high magnification (6,000 times, compared to 400 times in standard ICSI) to identify and select the highest-quality sperm based on detailed internal morphological criteria. IMSI can detect subtle sperm head abnormalities invisible at standard ICSI magnification. It is recommended for high DNA fragmentation, repeated IVF failure, or very poor sperm morphology.
Preimplantation Genetic Testing (PGT)
PGT involves biopsy of a few cells from the blastocyst-stage embryo followed by genetic analysis. PGT-A screens embryos for chromosomal number abnormalities (aneuploidies), identifying euploid (chromosomally normal) embryos for transfer. This reduces miscarriage rates and improves implantation rates per transfer, particularly in women above 37 and those with recurrent miscarriage or repeated IVF failure. PGT-M tests for specific inherited single gene disorders such as thalassaemia, sickle cell disease, cystic fibrosis, and Huntington disease.
Endometrial Receptivity Analysis (ERA)
The ERA test analyses the gene expression profile of the endometrial lining to determine the precise window of implantation. For the majority of women, this coincides with standard transfer timing. However, 25 to 30 percent have a displaced window, which can be identified and corrected with ERA to personalise transfer timing and improve implantation rates.
IVF and ICSI Treatment Across Samarth IVF Centres in India
Samarth IVF delivers world-class IVF and ICSI treatment across 14 centres in India. Our full-service IVF centres are equipped with advanced embryology laboratories, stimulation monitoring, egg retrieval suites, embryo transfer facilities, and vitrification programmes.
Sambhajinagar (Aurangabad), Maharashtra: Main HQ with full surgical and IVF facilities, plus 2 Level-1 Centres
Washim, Maharashtra | Buldhana, Maharashtra | Parbhani, Maharashtra | Omerga (Umarga), Maharashtra | Gondia, Maharashtra
Dehradun, Uttarakhand | Jamnagar, Gujarat | Kalaburagi (Gulbarga), Karnataka | Bhopal, Madhya Pradesh | Farrukhabad, Uttar Pradesh | Lucknow, Uttar Pradesh
Why Choose Samarth IVF
Internationally benchmarked success rates against global standards.
Personalised protocols tailored to ovarian reserve, age, and diagnosis.
Advanced embryology laboratory with state-of-the-art incubators & ICSI/IMSI.
Blastocyst culture as standard (Day 5 to 6) to select the best embryos.
Transparent counselling and honest discussion of costs and success probabilities.
Full range of advanced tech: PGT-A, PGT-M, ERA, LAH, IMSI available.
IVF and ICSI Cost in India
IVF treatment costs in India are significantly lower than in Western countries, making India a preferred destination for both domestic and international fertility patients. At Samarth IVF, pricing is fully transparent with no hidden charges. The total cost of an IVF cycle depends on the specific protocol, medications required, whether ICSI is indicated, and any additional procedures such as PGT or ERA.
Samarth IVF provides a complete personalised cost estimate at your pre-treatment consultation, covering all foreseeable components of your planned cycle.
Risks and Side Effects of IVF
IVF is a well-established, safe medical procedure. The vast majority of patients complete an IVF cycle without significant complications. However, all patients should be counselled about the following:
Ovarian Hyperstimulation Syndrome (OHSS):
The most important IVF-specific risk. Excessive ovarian response causing bloating and fluid accumulation. Severe OHSS occurs in 1 to 2 percent of cycles. Managed through careful protocol selection, close monitoring, GnRH agonist trigger, and freeze-all strategies.
Multiple pregnancy:
The risk of twins or higher-order multiples from IVF. Managed by single embryo transfer policy.
Egg retrieval complications:
Rare bleeding, infection, or injury during follicle aspiration.
Emotional impact:
IVF is emotionally demanding. Anxiety, stress, and grief after failed cycles are common. Samarth IVF provides counselling support.
Treatment not resulting in pregnancy:
Each cycle has a 45 to 55 percent success rate (under 35). Some cycles will fail. Review and adjustments optimise future attempts.
- FAQ
FREQUENTLY ASKED QUESTIONS
In standard IVF, prepared sperm are placed around each egg in a culture dish and fertilisation occurs when a sperm independently penetrates the egg. In ICSI, a single sperm is selected and injected directly into each egg by the embryologist. ICSI is used when sperm quality is poor, when previous IVF fertilisation was low, or when surgically retrieved sperm is used. ICSI achieves higher fertilisation rates per egg and is now used in most IVF cycles worldwide.
The number of eggs retrieved depends primarily on ovarian reserve (AMH and AFC) and stimulation response. In a normal responder, 8 to 15 eggs are typically retrieved. Women with PCOS may produce 15 to 25 or more (requiring careful management to prevent OHSS). Women with diminished reserve may produce 2 to 6 eggs. Not all retrieved eggs will be mature, and not all mature eggs will fertilise or develop into transferable embryos. Your specialist will give you a personalised expectation based on your AMH and AFC.
Single embryo transfer (SET) is the standard recommendation at Samarth IVF for patients under 38 with good-quality blastocyst-stage embryos. SET eliminates the risk of twin or higher-order multiple pregnancy while maintaining excellent pregnancy rates when embryo quality and endometrial receptivity are optimised. Double embryo transfer is considered in selected cases based on age, embryo quality, and clinical history. Your specialist will discuss the transfer strategy personalised to your situation.
Egg retrieval is performed under intravenous sedation, so you will be comfortable and unaware during the procedure itself. After waking up, mild to moderate pelvic cramping similar to period pain is common and typically managed well with oral pain relief. Most women are discharged 2 to 4 hours after the procedure and return to light activities the following day. Significant pain after egg retrieval is uncommon and should be reported to your medical team.
Good-quality embryos that are not used in the fresh transfer are vitrified (flash-frozen) and stored in the embryology laboratory. Frozen embryos can be used in future frozen embryo transfer (FET) cycles without repeating ovarian stimulation and egg retrieval. Embryo storage fees apply. At the end of treatment, couples are asked to make a decision about remaining stored embryos, with options including continued storage, use in further FET cycles, donation to other patients (with consent), donation to research, or disposal.
A complete IVF cycle from the start of stimulation injections to the pregnancy test takes approximately 4 to 6 weeks. Stimulation lasts 10 to 12 days. Egg retrieval is 36 hours after the trigger injection. Embryo culture lasts 5 to 6 days to blastocyst stage. Fresh embryo transfer is typically on Day 5 to 6 after egg retrieval. The pregnancy test is 14 days after transfer. If a freeze-all strategy is used, the FET cycle in a subsequent month adds approximately 3 to 4 weeks.
Yes. Low AMH indicates diminished ovarian reserve but does not make IVF impossible. The stimulation protocol is tailored to optimise response at lower doses. Some women with very low AMH still retrieve usable eggs and achieve successful pregnancies. The key is acting promptly, as ovarian reserve continues to decline with time. For women with AMH near zero, egg donation offers success rates of 50 to 60 percent per transfer regardless of recipient age. Your specialist will honestly discuss whether own-egg IVF or egg donation is the more realistic option for your specific AMH level and age.
IVF is a well-established, safe procedure. The main risk specific to IVF is Ovarian Hyperstimulation Syndrome (OHSS), which occurs in severe form in approximately 1 to 2 percent of cycles. At Samarth IVF, OHSS risk is carefully managed through protocol selection, close monitoring, appropriate trigger choice, and freeze-all strategies when needed. Other risks including bleeding or infection from egg retrieval are rare. The emotional and psychological demands of treatment are real and our team provides support throughout.
Many patients succeed on the first or second cycle. Cumulative success rates across 3 complete IVF cycles (including FET cycles from each stimulation) reach 65 to 80 percent for women under 38. The number of cycles recommended depends on age, diagnosis, reserve, and embryo quality. Your specialist will review each cycle in detail after completion and discuss the optimal plan for subsequent attempts based on what was learned from the previous cycle.
Full IVF and ICSI treatment including ovarian stimulation, egg retrieval, embryology, embryo transfer, and vitrification is available at Samarth IVF main centres with complete IVF laboratory infrastructure. Patients attending our satellite centres for monitoring and initial consultation are coordinated seamlessly with the nearest full-service IVF centre. Our 14 + centre network across India ensures accessible, high-quality IVF care for patients in Maharashtra, Gujarat, Madhya Pradesh, Uttar Pradesh, Uttarakhand, and Karnataka.
Ready to Take the Next Step?
Speak with our IVF specialists today to start your journey to parenthood.
